- Home
- RMTI vs ANTX Comparison
RMTI vs ANTX Comparison
Compare RMTI & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- ANTX
- Stock Information
- Founded
- RMTI 1994
- ANTX 2017
- Country
- RMTI United States
- ANTX United States
- Employees
- RMTI N/A
- ANTX N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- RMTI Health Care
- ANTX Health Care
- Exchange
- RMTI Nasdaq
- ANTX Nasdaq
- Market Cap
- RMTI 32.5M
- ANTX 33.2M
- IPO Year
- RMTI 1998
- ANTX 2022
- Fundamental
- Price
- RMTI $1.07
- ANTX $1.08
- Analyst Decision
- RMTI Strong Buy
- ANTX Buy
- Analyst Count
- RMTI 2
- ANTX 2
- Target Price
- RMTI $4.00
- ANTX $2.00
- AVG Volume (30 Days)
- RMTI 462.8K
- ANTX 258.4K
- Earning Date
- RMTI 08-07-2025
- ANTX 08-12-2025
- Dividend Yield
- RMTI N/A
- ANTX N/A
- EPS Growth
- RMTI N/A
- ANTX N/A
- EPS
- RMTI N/A
- ANTX N/A
- Revenue
- RMTI $97,727,000.00
- ANTX N/A
- Revenue This Year
- RMTI N/A
- ANTX N/A
- Revenue Next Year
- RMTI $11.16
- ANTX N/A
- P/E Ratio
- RMTI N/A
- ANTX N/A
- Revenue Growth
- RMTI 12.82
- ANTX N/A
- 52 Week Low
- RMTI $0.78
- ANTX $0.87
- 52 Week High
- RMTI $5.15
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- RMTI 55.84
- ANTX 48.42
- Support Level
- RMTI $0.80
- ANTX $1.05
- Resistance Level
- RMTI $1.42
- ANTX $1.10
- Average True Range (ATR)
- RMTI 0.10
- ANTX 0.04
- MACD
- RMTI 0.03
- ANTX 0.00
- Stochastic Oscillator
- RMTI 45.31
- ANTX 50.00
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.